Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Atrial Appendage Micrografts Transplanted During Coronary Artery Bypass Surgery: the AAMS2 Randomized, Double-blinded, and Placebo-controlled Trial

NCT05632432 is registered in ClinicalTrials.gov with Hospital District of Helsinki and Uusimaa as lead sponsor.

NCT NCT05632432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05632432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Atrial Appendage Micrografts Transplanted During Coronary Artery Bypass Surgery: the AAMS2 Randomized, Double-blinded, and Placebo-controlled Trial
Lead sponsor
Hospital District of Helsinki and Uusimaa
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2024
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, heart failure nyha class ii, heart failure nyha class iii, heart failure nyha class iv, heart failure, systolic, ischemic cardiomyopathy, ischemic heart disease